Clinical Trial Update: Molecular Analysis of Retinoblastoma

View source ↗

Summary

The clinical trial update reports that the study analyzing the molecular characteristics of retinoblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinoblastoma

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Retinoblastoma | Status: COMPLETED